Effect of Regorafenib on Digoxin and Rosuvastatin in Patients With Advanced Solid Malignant Tumors.
Clinical trial NCT02106845 · COMPLETED
Trial details
- NCT number
- NCT02106845
- Sponsor
- Bayer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-04-22
- Primary completion
- 2015-04-27
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.